Europe Dialysis Market by Dialysis Type (Hemodialysis and Peritoneal Dialysis), Products & Services (Equipment, Consumables, Drugs, and Services), End User (In-center Dialysis, and Home Dialysis) – Opportunity Analysis and Industry Forecast, 2024–2030

Europe Dialysis Market

Industry:  Life Sciences & Healthcare | Publish Date: Feb 2024 | No of Pages:  152 | No. Tables:  108 | No. Figures:  73

Market Overview:

The Europe Dialysis Market size was valued at USD 35.93 billion in 2023, and is expected to reach USD 46.61 billion by 2030, with a CAGR of 3.8% from 2024 to 2030.

Europe dialysis market refers to the global healthcare sector focused on the provision of artificial kidney functions to individuals suffering from impaired renal function. Dialysis is a life-sustaining medical procedure employed to manage patients with end-stage renal disease (ESRD) or acute kidney injuries.

This market encompasses a spectrum of products and services, including hemodialysis and peritoneal dialysis equipment, dialysis consumables, and associated pharmaceuticals. With the rising prevalence of kidney-related disorders and the increasing aging population, the market plays a critical role in delivering essential renal care, aiming to enhance patients' quality of life and improve overall healthcare outcomes.

Technological Advancements in Dialysis Machines is Driving the Market to Grow:

Continuous innovation in dialysis machine technology is a significant driver for the Europe dialysis market. Modern dialysis machines are equipped with advanced features, including improved filtration mechanisms, enhanced portability, and user-friendly interfaces.

These technological advancements not only enhance the overall efficiency of dialysis treatments but also contribute to a more comfortable and convenient experience for both healthcare providers and patients. As these machines evolve, they offer better precision in removing toxins from the blood, leading to improved outcomes and patient satisfaction.

The integration of smart technologies and connectivity features further facilitates remote monitoring and data management, streamlining the overall dialysis process and supporting personalized treatment plans. The continuous pursuit of technological excellence in dialysis machines positions them as essential tools in the management of kidney-related disorders, driving the growth of the Europe dialysis market.

 

Rising Diabetes and Hypertension Cases Propels the Market Expansion:

The surge in diabetes and hypertension cases in the country contributes significantly to the growth of the market. These chronic conditions, especially when unmanaged, can lead to kidney damage and eventually chronic kidney disease (CKD).

With the increasing prevalence of diabetes and hypertension, there is a corresponding rise in the incidence of CKD, necessitating the use of dialysis as a crucial therapeutic intervention. The expanding patient pool with these comorbidities underscores the importance of dialysis services in managing kidney-related complications, driving the demand for dialysis treatments.

The risk associated with Infection and Complications Hinders Market Expansion.

One of the significant challenges in the Europe dialysis market is the inherent risk of infections and complications associated with these procedures. Poor adherence to stringent hygiene practices and inadequate sterilization measures can elevate infections, posing a threat to patient health.

Additionally, complications arising from the dialysis process itself can contribute to treatment challenges. Addressing these risks through rigorous quality control measures, training healthcare professionals, and promoting adherence to established protocols is essential to enhance the safety profile of dialysis treatments, fostering better patient outcomes and confidence in the market.

Introduction of At- Home Dialysis Solutions Creates Lucrative Growth Opportunity for the Market:

The introduction of At- Home Dialysis Solutions reduces the need for frequent hospital visits, and provides a flexible kidney care option. As more individuals prefer the convenience of managing their dialysis in the comfort of their homes, companies that provide user-friendly and portable dialysis equipment stand to capture a significant market share. By addressing the growing demand for home-based healthcare solutions, the dialysis market can attract a broader customer base and foster long-term patient satisfaction, contributing to market growth.

Germany Holds the Dominant Market Share in the Europe Dialysis Market

The technological advancements in healthcare are driving substantial growth in the dialysis market by extending life expectancy and enabling a larger demographic to live longer with chronic conditions. The advent of user-friendly home haemodialysis machines with intuitive interfaces and remote monitoring capabilities has revolutionized patient care. Patients can comfortably perform haemodialysis at home, reducing the need for frequent hospital visits.

Moreover, the surge in the dialysis market is prominently influenced by the aging demographic, marking a substantial impact on the prevalence and management of kidney-related disorders. As individuals age, the heightened risk of chronic conditions such as diabetes and hypertension become more pronounced, leading to an increased incidence of Chronic Kidney Disease (CKD). This demographic shift underscores the escalating demand for dialysis services as a crucial component in the management of kidney health in the aging population.

 

Germany is the Fastest Growing Country in the Market

This is attributed to technological advancements in healthcare are driving substantial growth in the dialysis market by extending life expectancy and enabling a larger demographic to live longer with chronic conditions. The advent of userfriendly home haemodialysis machines with intuitive interfaces and remote monitoring capabilities has revolutionized patient care. Patients can comfortably perform haemodialysis at home, reducing the need for frequent hospital visits.

Moreover, the surge in Germany dialysis market is prominently influenced by the aging demographic, marking a substantial impact on the prevalence and management of kidney-related disorders. As individuals age, the heightened risk of chronic conditions such as diabetes and hypertension becomes more pronounced, leading to an increased incidence of chronic kidney disease (CKD). This demographic shift underscores the escalating demand for dialysis services as a crucial component in the management of kidney health in the aging population.

 

Competitive Landscape

Several market players operating in the Europe dialysis market include Baxter International, Inc., DaVita Inc., Nikkiso Co. Ltd., NxStage Medical, Inc., Asahi Kasei Corporation, Medicators, Inc, Fresenius Medical Care AG & Co. KGaA, Nipro Corporation, B. Braun Avitum AG, Diaverum Deutschland GmbH, and others.

Key Market Segments

By Dialysis Type

  • Hemo Dialysis

  • Peritoneal Dialysis

By Products & Services

  • Equipment

  • Consumables

  • Drugs

  • Services

By End User

  • In-center Dialysis

  • Home Dialysis

By Region        

  • Europe    

    • UK

    • Germany

    • Spain

    • France

    • Italy

    • Rest of Europe

REPORT SCOPE AND SEGMENTATION:

Parameters

Details

Market Size in 2023

USD 35.93 Billion

Revenue Forecast in 2030

USD 46.61 Billion

Growth Rate

CAGR of 3.8% from 2024 to 2030

Analysis Period

2023–2030

Base Year Considered

2023

Forecast Period

2024–2030

Market Size Estimation

Billion (USD)

Growth Factors

  • Technological Advancements in Dialysis Machines

  • Rising Diabetes and Hypertension Cases

Countries Covered

5

Companies Profiled

10

Market Share

Available for 10 companies

Customization Scope

Free customization (equivalent up to 80 working hours of analysts) after purchase. Addition or alteration to country, regional, and segment scope.

Pricing and Purchase Options

Avail customized purchase options to meet your exact research needs.

Test

1      INTRODUCTION

           1.1      REPORT DESCRIPTION

           1.2      RESEARCH METHODOLOGY

                         1.2.1      SECONDARY RESEARCH

                         1.2.2      DATA ANALYSIS FRAMEWORK

                         1.2.3      MARKET SIZE ESTIMATION

                         1.2.4      FORECASTING

                         1.2.5      PRIMARY RESEARCH AND DATA VALIDATION

2      EUROPE DIALYSIS MARKET – EXECUTIVE SUMMARY

           2.1.      MARKET SNAPSHOT, 2023 - 2030, MILLION USD

3      PORTER’S FIVE FORCE MODEL ANALYSIS

           3.1      BARGAINING POWER OF SUPPLIERS

           3.2      BARGAINING POWER OF BUYERS

           3.3      DEGREE OF COMPETITION

           3.4      THREAT OF SUBSTITUTE

           3.5      THREAT OF NEW ENTRANTS

4      MARKET SHARE ANALYSIS

           4.1      MARKET SHARE ANALYSIS OF TOP PROVIDERS, 2023

5      MARKET DYNAMICS

           5.1      GROWTH DRIVERS

                         5.1.1      DRIVER 1

                         5.1.2      DRIVER 2

                         5.1.3      DRIVER 3

                         5.1.4      DRIVER 4

           5.2      CHALLENGES

                         5.2.1      CHALLENGE 1

                         5.2.2      CHALLENGE 2

                         5.2.3      CHALLENGE 3

                         5.2.4      CHALLENGE 4

           5.3      OPPORTUNITIES

                         5.3.1      OPPORTUNITY 1

                         5.3.2      OPPORTUNITY 2

6      EUROPE DIALYSIS MARKET BY DIALYSIS TYPE

           6.1      OVERVIEW

           6.2      HEMO DIALYSIS

                         6.2.1      HEMO DIALYSIS MARKET, BY COUNTRY

           6.3      PERITONEAL DIALYSIS

                         6.3.1      PERITONEAL DIALYSIS MARKET, BY COUNTRY

7      EUROPE DIALYSIS MARKET BY PRODUCTS AND SERVICES

           7.1      OVERVIEW

           7.2      EQUIPMENT

                         7.2.1      EQUIPMENT MARKET, BY COUNTRY

           7.3      CONSUMABLES

                         7.3.1      CONSUMABLES MARKET, BY COUNTRY

           7.4      DRUGS

                         7.4.1      DRUGS MARKET, BY COUNTRY

           7.5      SERVICES

                         7.5.1      SERVICES MARKET, BY COUNTRY

8      EUROPE DIALYSIS MARKET BY END USER

           8.1      OVERVIEW

           8.2      IN-CENTER DIALYSIS

                         8.2.1      IN-CENTER DIALYSIS MARKET, BY COUNTRY

           8.3      HOME DIALYSIS

                         8.3.1      HOME DIALYSIS MARKET, BY COUNTRY

9     EUROPE DIALYSIS MARKET, BY COUNTRY

           9.1     OVERVIEW

           9.2     GERMANY

                         9.2.1     EUROPE DIALYSIS MARKET, BY DIALYSIS TYPE

                         9.2.2     EUROPE DIALYSIS MARKET, BY PRODUCTS AND SERVICES

                         9.2.3     EUROPE DIALYSIS MARKET, BY END USER

           9.3     FRANCE

                         9.3.1     EUROPE DIALYSIS MARKET, BY DIALYSIS TYPE

                         9.3.2     EUROPE DIALYSIS MARKET, BY PRODUCTS AND SERVICES

                         9.3.3     EUROPE DIALYSIS MARKET, BY END USER

           9.4     ITALY

                         9.4.1     EUROPE DIALYSIS MARKET, BY DIALYSIS TYPE

                         9.4.2     EUROPE DIALYSIS MARKET, BY PRODUCTS AND SERVICES

                         9.4.3     EUROPE DIALYSIS MARKET, BY END USER

           9.5     SPAIN

                         9.5.1     EUROPE DIALYSIS MARKET, BY DIALYSIS TYPE

                         9.5.2     EUROPE DIALYSIS MARKET, BY PRODUCTS AND SERVICES

                         9.5.3     EUROPE DIALYSIS MARKET, BY END USER

           9.6     UNITED KINGDOM

                         9.6.1     EUROPE DIALYSIS MARKET, BY DIALYSIS TYPE

                         9.6.2     EUROPE DIALYSIS MARKET, BY PRODUCTS AND SERVICES

                         9.6.3     EUROPE DIALYSIS MARKET, BY END USER

           9.7     RUSSIA

                         9.7.1     EUROPE DIALYSIS MARKET, BY DIALYSIS TYPE

                         9.7.2     EUROPE DIALYSIS MARKET, BY PRODUCTS AND SERVICES

                         9.7.3     EUROPE DIALYSIS MARKET, BY END USER

           9.8     SWITZERLAND

                         9.8.1     EUROPE DIALYSIS MARKET, BY DIALYSIS TYPE

                         9.8.2     EUROPE DIALYSIS MARKET, BY PRODUCTS AND SERVICES

                         9.8.3     EUROPE DIALYSIS MARKET, BY END USER

           9.9     SWEDEN

                         9.9.1     EUROPE DIALYSIS MARKET, BY DIALYSIS TYPE

                         9.9.2     EUROPE DIALYSIS MARKET, BY PRODUCTS AND SERVICES

                         9.9.3     EUROPE DIALYSIS MARKET, BY END USER

           9.10     NORWAY

                         9.10.1     EUROPE DIALYSIS MARKET, BY DIALYSIS TYPE

                         9.10.2     EUROPE DIALYSIS MARKET, BY PRODUCTS AND SERVICES

                         9.10.3     EUROPE DIALYSIS MARKET, BY END USER

           9.11     DENMARK

                         9.11.1     EUROPE DIALYSIS MARKET, BY DIALYSIS TYPE

                         9.11.2     EUROPE DIALYSIS MARKET, BY PRODUCTS AND SERVICES

                         9.11.3     EUROPE DIALYSIS MARKET, BY END USER

           9.12     NETHERLANDS

                         9.12.1     EUROPE DIALYSIS MARKET, BY DIALYSIS TYPE

                         9.12.2     EUROPE DIALYSIS MARKET, BY PRODUCTS AND SERVICES

                         9.12.3     EUROPE DIALYSIS MARKET, BY END USER

           9.13     REST OF EUROPE

                         9.13.1     EUROPE DIALYSIS MARKET, BY DIALYSIS TYPE

                         9.13.2     EUROPE DIALYSIS MARKET, BY PRODUCTS AND SERVICES

                         9.13.3     EUROPE DIALYSIS MARKET, BY END USER

10   COMPANY PROFILES

           10.1   BAXTER INTERNATIONAL INC.

                         10.1.1   COMPANY OVERVIEW

                         10.1.2   COMPANY SNAPSHOT

                         10.1.3   OPERATING BUSINESS SEGMENTS

                         10.1.4   PRODUCT PORTFOLIO

                         10.1.5   BUSINESS PERFORMANCE

                         10.1.6   BUSINESS SEGMENTS

                         10.1.7   GEOGRAPHIC SEGMENTS

                         10.1.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         10.1.9   PRIMARY MARKET COMPETITORS

           10.2   DAVITA INC.

                         10.2.1   COMPANY OVERVIEW

                         10.2.2   COMPANY SNAPSHOT

                         10.2.3   OPERATING BUSINESS SEGMENTS

                         10.2.4   PRODUCT PORTFOLIO

                         10.2.5   BUSINESS PERFORMANCE

                         10.2.6   BUSINESS SEGMENTS

                         10.2.7   GEOGRAPHIC SEGMENTS

                         10.2.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         10.2.9   PRIMARY MARKET COMPETITORS

           10.3   NIKKISO CO. LTD.

                         10.3.1   COMPANY OVERVIEW

                         10.3.2   COMPANY SNAPSHOT

                         10.3.3   OPERATING BUSINESS SEGMENTS

                         10.3.4   PRODUCT PORTFOLIO

                         10.3.5   BUSINESS PERFORMANCE

                         10.3.6   BUSINESS SEGMENTS

                         10.3.7   GEOGRAPHIC SEGMENTS

                         10.3.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         10.3.9   PRIMARY MARKET COMPETITORS

           10.4   NXSTAGE MEDICAL, INC.

                         10.4.1   COMPANY OVERVIEW

                         10.4.2   COMPANY SNAPSHOT

                         10.4.3   OPERATING BUSINESS SEGMENTS

                         10.4.4   PRODUCT PORTFOLIO

                         10.4.5   BUSINESS PERFORMANCE

                         10.4.6   BUSINESS SEGMENTS

                         10.4.7   GEOGRAPHIC SEGMENTS

                         10.4.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         10.4.9   PRIMARY MARKET COMPETITORS

           10.5   ASAHI KASEI CORPORATION

                         10.5.1   COMPANY OVERVIEW

                         10.5.2   COMPANY SNAPSHOT

                         10.5.3   OPERATING BUSINESS SEGMENTS

                         10.5.4   PRODUCT PORTFOLIO

                         10.5.5   BUSINESS PERFORMANCE

                         10.5.6   BUSINESS SEGMENTS

                         10.5.7   GEOGRAPHIC SEGMENTS

                         10.5.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         10.5.9   PRIMARY MARKET COMPETITORS

           10.6   MEDICATORS, INC.

                         10.6.1   COMPANY OVERVIEW

                         10.6.2   COMPANY SNAPSHOT

                         10.6.3   OPERATING BUSINESS SEGMENTS

                         10.6.4   PRODUCT PORTFOLIO

                         10.6.5   BUSINESS PERFORMANCE

                         10.6.6   BUSINESS SEGMENTS

                         10.6.7   GEOGRAPHIC SEGMENTS

                         10.6.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         10.6.9   PRIMARY MARKET COMPETITORS

           10.7   FRESENIUS MEDICAL CARE AG AND CO. KGAA

                         10.7.1   COMPANY OVERVIEW

                         10.7.2   COMPANY SNAPSHOT

                         10.7.3   OPERATING BUSINESS SEGMENTS

                         10.7.4   PRODUCT PORTFOLIO

                         10.7.5   BUSINESS PERFORMANCE

                         10.7.6   BUSINESS SEGMENTS

                         10.7.7   GEOGRAPHIC SEGMENTS

                         10.7.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         10.7.9   PRIMARY MARKET COMPETITORS

           10.8   NIPRO CORPORATION

                         10.8.1   COMPANY OVERVIEW

                         10.8.2   COMPANY SNAPSHOT

                         10.8.3   OPERATING BUSINESS SEGMENTS

                         10.8.4   PRODUCT PORTFOLIO

                         10.8.5   BUSINESS PERFORMANCE

                         10.8.6   BUSINESS SEGMENTS

                         10.8.7   GEOGRAPHIC SEGMENTS

                         10.8.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         10.8.9   PRIMARY MARKET COMPETITORS

           10.9   B. BRAUN AVITUM AG

                         10.9.1   COMPANY OVERVIEW

                         10.9.2   COMPANY SNAPSHOT

                         10.9.3   OPERATING BUSINESS SEGMENTS

                         10.9.4   PRODUCT PORTFOLIO

                         10.9.5   BUSINESS PERFORMANCE

                         10.9.6   BUSINESS SEGMENTS

                         10.9.7   GEOGRAPHIC SEGMENTS

                         10.9.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         10.9.9   PRIMARY MARKET COMPETITORS

           10.10   DIAVERUM DEUTSCHLAND GMBH

                         10.10.1   COMPANY OVERVIEW

                         10.10.2   COMPANY SNAPSHOT

                         10.10.3   OPERATING BUSINESS SEGMENTS

                         10.10.4   PRODUCT PORTFOLIO

                         10.10.5   BUSINESS PERFORMANCE

                         10.10.6   BUSINESS SEGMENTS

                         10.10.7   GEOGRAPHIC SEGMENTS

                         10.10.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         10.10.9   PRIMARY MARKET COMPETITORS

LIST OF TABLES

TABLE 1. EUROPE EUROPE DIALYSIS MARKET VALUE, BY DIALYSIS TYPE, 2023-2030, (MILLION USD)

TABLE 2. HEMO DIALYSIS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 3. PERITONEAL DIALYSIS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 4. EUROPE EUROPE DIALYSIS MARKET VALUE, BY PRODUCTS AND SERVICES, 2023-2030, (MILLION USD)

TABLE 5. EQUIPMENT, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 6. CONSUMABLES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 7. DRUGS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 8. SERVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 9. EUROPE EUROPE DIALYSIS MARKET VALUE, BY END USER, 2023-2030, (MILLION USD)

TABLE 10. IN-CENTER DIALYSIS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 11. HOME DIALYSIS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 12. EUROPE EUROPE DIALYSIS MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 13. GERMANY EUROPE DIALYSIS MARKET VALUE, BY DIALYSIS TYPE, 2023-2030, (MILLION USD)

TABLE 14. GERMANY EUROPE DIALYSIS MARKET VALUE, BY PRODUCTS AND SERVICES, 2023-2030, (MILLION USD)

TABLE 15. GERMANY EUROPE DIALYSIS MARKET VALUE, BY END USER, 2023-2030, (MILLION USD)

TABLE 16. FRANCE EUROPE DIALYSIS MARKET VALUE, BY DIALYSIS TYPE, 2023-2030, (MILLION USD)

TABLE 17. FRANCE EUROPE DIALYSIS MARKET VALUE, BY PRODUCTS AND SERVICES, 2023-2030, (MILLION USD)

TABLE 18. FRANCE EUROPE DIALYSIS MARKET VALUE, BY END USER, 2023-2030, (MILLION USD)

TABLE 19. ITALY EUROPE DIALYSIS MARKET VALUE, BY DIALYSIS TYPE, 2023-2030, (MILLION USD)

TABLE 20. ITALY EUROPE DIALYSIS MARKET VALUE, BY PRODUCTS AND SERVICES, 2023-2030, (MILLION USD)

TABLE 21. ITALY EUROPE DIALYSIS MARKET VALUE, BY END USER, 2023-2030, (MILLION USD)

TABLE 22. SPAIN EUROPE DIALYSIS MARKET VALUE, BY DIALYSIS TYPE, 2023-2030, (MILLION USD)

TABLE 23. SPAIN EUROPE DIALYSIS MARKET VALUE, BY PRODUCTS AND SERVICES, 2023-2030, (MILLION USD)

TABLE 24. SPAIN EUROPE DIALYSIS MARKET VALUE, BY END USER, 2023-2030, (MILLION USD)

TABLE 25. UNITED KINGDOM EUROPE DIALYSIS MARKET VALUE, BY DIALYSIS TYPE, 2023-2030, (MILLION USD)

TABLE 26. UNITED KINGDOM EUROPE DIALYSIS MARKET VALUE, BY PRODUCTS AND SERVICES, 2023-2030, (MILLION USD)

TABLE 27. UNITED KINGDOM EUROPE DIALYSIS MARKET VALUE, BY END USER, 2023-2030, (MILLION USD)

TABLE 28. RUSSIA EUROPE DIALYSIS MARKET VALUE, BY DIALYSIS TYPE, 2023-2030, (MILLION USD)

TABLE 29. RUSSIA EUROPE DIALYSIS MARKET VALUE, BY PRODUCTS AND SERVICES, 2023-2030, (MILLION USD)

TABLE 30. RUSSIA EUROPE DIALYSIS MARKET VALUE, BY END USER, 2023-2030, (MILLION USD)

TABLE 31. SWITZERLAND EUROPE DIALYSIS MARKET VALUE, BY DIALYSIS TYPE, 2023-2030, (MILLION USD)

TABLE 32. SWITZERLAND EUROPE DIALYSIS MARKET VALUE, BY PRODUCTS AND SERVICES, 2023-2030, (MILLION USD)

TABLE 33. SWITZERLAND EUROPE DIALYSIS MARKET VALUE, BY END USER, 2023-2030, (MILLION USD)

TABLE 34. SWEDEN EUROPE DIALYSIS MARKET VALUE, BY DIALYSIS TYPE, 2023-2030, (MILLION USD)

TABLE 35. SWEDEN EUROPE DIALYSIS MARKET VALUE, BY PRODUCTS AND SERVICES, 2023-2030, (MILLION USD)

TABLE 36. SWEDEN EUROPE DIALYSIS MARKET VALUE, BY END USER, 2023-2030, (MILLION USD)

TABLE 37. NORWAY EUROPE DIALYSIS MARKET VALUE, BY DIALYSIS TYPE, 2023-2030, (MILLION USD)

TABLE 38. NORWAY EUROPE DIALYSIS MARKET VALUE, BY PRODUCTS AND SERVICES, 2023-2030, (MILLION USD)

TABLE 39. NORWAY EUROPE DIALYSIS MARKET VALUE, BY END USER, 2023-2030, (MILLION USD)

TABLE 40. DENMARK EUROPE DIALYSIS MARKET VALUE, BY DIALYSIS TYPE, 2023-2030, (MILLION USD)

TABLE 41. DENMARK EUROPE DIALYSIS MARKET VALUE, BY PRODUCTS AND SERVICES, 2023-2030, (MILLION USD)

TABLE 42. DENMARK EUROPE DIALYSIS MARKET VALUE, BY END USER, 2023-2030, (MILLION USD)

TABLE 43. NETHERLANDS EUROPE DIALYSIS MARKET VALUE, BY DIALYSIS TYPE, 2023-2030, (MILLION USD)

TABLE 44. NETHERLANDS EUROPE DIALYSIS MARKET VALUE, BY PRODUCTS AND SERVICES, 2023-2030, (MILLION USD)

TABLE 45. NETHERLANDS EUROPE DIALYSIS MARKET VALUE, BY END USER, 2023-2030, (MILLION USD)

TABLE 46. REST OF EUROPE EUROPE DIALYSIS MARKET VALUE, BY DIALYSIS TYPE, 2023-2030, (MILLION USD)

TABLE 47. REST OF EUROPE EUROPE DIALYSIS MARKET VALUE, BY PRODUCTS AND SERVICES, 2023-2030, (MILLION USD)

TABLE 48. REST OF EUROPE EUROPE DIALYSIS MARKET VALUE, BY END USER, 2023-2030, (MILLION USD)

TABLE 49. BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT

TABLE 50. BAXTER INTERNATIONAL INC.: OPERATING BUSINESS SEGMENTS

TABLE 51. BAXTER INTERNATIONAL INC.: PRODUCT PORTFOLIO

TABLE 52. BAXTER INTERNATIONAL INC.: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 53. BAXTER INTERNATIONAL INC.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 54. BAXTER INTERNATIONAL INC.: KEY STRATERGY

TABLE 55. DAVITA INC.: COMPANY SNAPSHOT

TABLE 56. DAVITA INC.: OPERATING BUSINESS SEGMENTS

TABLE 57. DAVITA INC.: PRODUCT PORTFOLIO

TABLE 58. DAVITA INC.: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 59. DAVITA INC.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 60. DAVITA INC.: KEY STRATERGY

TABLE 61. NIKKISO CO. LTD.: COMPANY SNAPSHOT

TABLE 62. NIKKISO CO. LTD.: OPERATING BUSINESS SEGMENTS

TABLE 63. NIKKISO CO. LTD.: PRODUCT PORTFOLIO

TABLE 64. NIKKISO CO. LTD.: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 65. NIKKISO CO. LTD.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 66. NIKKISO CO. LTD.: KEY STRATERGY

TABLE 67. NXSTAGE MEDICAL, INC.: COMPANY SNAPSHOT

TABLE 68. NXSTAGE MEDICAL, INC.: OPERATING BUSINESS SEGMENTS

TABLE 69. NXSTAGE MEDICAL, INC.: PRODUCT PORTFOLIO

TABLE 70. NXSTAGE MEDICAL, INC.: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 71. NXSTAGE MEDICAL, INC.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 72. NXSTAGE MEDICAL, INC.: KEY STRATERGY

TABLE 73. ASAHI KASEI CORPORATION: COMPANY SNAPSHOT

TABLE 74. ASAHI KASEI CORPORATION: OPERATING BUSINESS SEGMENTS

TABLE 75. ASAHI KASEI CORPORATION: PRODUCT PORTFOLIO

TABLE 76. ASAHI KASEI CORPORATION: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 77. ASAHI KASEI CORPORATION: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 78. ASAHI KASEI CORPORATION: KEY STRATERGY

TABLE 79. MEDICATORS, INC.: COMPANY SNAPSHOT

TABLE 80. MEDICATORS, INC.: OPERATING BUSINESS SEGMENTS

TABLE 81. MEDICATORS, INC.: PRODUCT PORTFOLIO

TABLE 82. MEDICATORS, INC.: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 83. MEDICATORS, INC.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 84. MEDICATORS, INC.: KEY STRATERGY

TABLE 85. FRESENIUS MEDICAL CARE AG AND CO. KGAA: COMPANY SNAPSHOT

TABLE 86. FRESENIUS MEDICAL CARE AG AND CO. KGAA: OPERATING BUSINESS SEGMENTS

TABLE 87. FRESENIUS MEDICAL CARE AG AND CO. KGAA: PRODUCT PORTFOLIO

TABLE 88. FRESENIUS MEDICAL CARE AG AND CO. KGAA: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 89. FRESENIUS MEDICAL CARE AG AND CO. KGAA: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 90. FRESENIUS MEDICAL CARE AG AND CO. KGAA: KEY STRATERGY

TABLE 91. NIPRO CORPORATION: COMPANY SNAPSHOT

TABLE 92. NIPRO CORPORATION: OPERATING BUSINESS SEGMENTS

TABLE 93. NIPRO CORPORATION: PRODUCT PORTFOLIO

TABLE 94. NIPRO CORPORATION: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 95. NIPRO CORPORATION: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 96. NIPRO CORPORATION: KEY STRATERGY

TABLE 97. B. BRAUN AVITUM AG: COMPANY SNAPSHOT

TABLE 98. B. BRAUN AVITUM AG: OPERATING BUSINESS SEGMENTS

TABLE 99. B. BRAUN AVITUM AG: PRODUCT PORTFOLIO

TABLE 100. B. BRAUN AVITUM AG: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 101. B. BRAUN AVITUM AG: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 102. B. BRAUN AVITUM AG: KEY STRATERGY

TABLE 103. DIAVERUM DEUTSCHLAND GMBH: COMPANY SNAPSHOT

TABLE 104. DIAVERUM DEUTSCHLAND GMBH: OPERATING BUSINESS SEGMENTS

TABLE 105. DIAVERUM DEUTSCHLAND GMBH: PRODUCT PORTFOLIO

TABLE 106. DIAVERUM DEUTSCHLAND GMBH: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 107. DIAVERUM DEUTSCHLAND GMBH: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 108. DIAVERUM DEUTSCHLAND GMBH: KEY STRATERGY

LIST OF FIGURES

FIGURE 1. BARGAINING POWER OF SUPPLIERS

FIGURE 2. BARGAINING POWER OF BUYERS

FIGURE 3. DEGREE OF COMPETITION

FIGURE 4. THREAT OF SUBSTITUTE

FIGURE 5. THREAT OF NEW ENTRANTS

FIGURE 6. EUROPE EUROPE DIALYSIS MARKET VALUE, BY DIALYSIS TYPE, 2023-2030, (MILLION USD)

FIGURE 7. HEMO DIALYSIS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 8. PERITONEAL DIALYSIS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 9. EUROPE EUROPE DIALYSIS MARKET VALUE, BY PRODUCTS AND SERVICES, 2023-2030, (MILLION USD)

FIGURE 10. EQUIPMENT, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 11. CONSUMABLES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 12. DRUGS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 13. SERVICES, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 14. EUROPE EUROPE DIALYSIS MARKET VALUE, BY END USER, 2023-2030, (MILLION USD)

FIGURE 15. IN-CENTER DIALYSIS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 16. HOME DIALYSIS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 17. EUROPE EUROPE DIALYSIS MARKET VALUE, BY REGION 2023-2030, (MILLION USD)

FIGURE 18. GERMANY EUROPE DIALYSIS MARKET VALUE, BY DIALYSIS TYPE 2023-2030, (MILLION USD)

FIGURE 19. GERMANY EUROPE DIALYSIS MARKET VALUE, BY PRODUCTS AND SERVICES 2023-2030, (MILLION USD)

FIGURE 20. GERMANY EUROPE DIALYSIS MARKET VALUE, BY END USER 2023-2030, (MILLION USD)

FIGURE 21. FRANCE EUROPE DIALYSIS MARKET VALUE, BY DIALYSIS TYPE 2023-2030, (MILLION USD)

FIGURE 22. FRANCE EUROPE DIALYSIS MARKET VALUE, BY PRODUCTS AND SERVICES 2023-2030, (MILLION USD)

FIGURE 23. FRANCE EUROPE DIALYSIS MARKET VALUE, BY END USER 2023-2030, (MILLION USD)

FIGURE 24. ITALY EUROPE DIALYSIS MARKET VALUE, BY DIALYSIS TYPE 2023-2030, (MILLION USD)

FIGURE 25. ITALY EUROPE DIALYSIS MARKET VALUE, BY PRODUCTS AND SERVICES 2023-2030, (MILLION USD)

FIGURE 26. ITALY EUROPE DIALYSIS MARKET VALUE, BY END USER 2023-2030, (MILLION USD)

FIGURE 27. SPAIN EUROPE DIALYSIS MARKET VALUE, BY DIALYSIS TYPE 2023-2030, (MILLION USD)

FIGURE 28. SPAIN EUROPE DIALYSIS MARKET VALUE, BY PRODUCTS AND SERVICES 2023-2030, (MILLION USD)

FIGURE 29. SPAIN EUROPE DIALYSIS MARKET VALUE, BY END USER 2023-2030, (MILLION USD)

FIGURE 30. UNITED KINGDOM EUROPE DIALYSIS MARKET VALUE, BY DIALYSIS TYPE 2023-2030, (MILLION USD)

FIGURE 31. UNITED KINGDOM EUROPE DIALYSIS MARKET VALUE, BY PRODUCTS AND SERVICES 2023-2030, (MILLION USD)

FIGURE 32. UNITED KINGDOM EUROPE DIALYSIS MARKET VALUE, BY END USER 2023-2030, (MILLION USD)

FIGURE 33. RUSSIA EUROPE DIALYSIS MARKET VALUE, BY DIALYSIS TYPE 2023-2030, (MILLION USD)

FIGURE 34. RUSSIA EUROPE DIALYSIS MARKET VALUE, BY PRODUCTS AND SERVICES 2023-2030, (MILLION USD)

FIGURE 35. RUSSIA EUROPE DIALYSIS MARKET VALUE, BY END USER 2023-2030, (MILLION USD)

FIGURE 36. SWITZERLAND EUROPE DIALYSIS MARKET VALUE, BY DIALYSIS TYPE 2023-2030, (MILLION USD)

FIGURE 37. SWITZERLAND EUROPE DIALYSIS MARKET VALUE, BY PRODUCTS AND SERVICES 2023-2030, (MILLION USD)

FIGURE 38. SWITZERLAND EUROPE DIALYSIS MARKET VALUE, BY END USER 2023-2030, (MILLION USD)

FIGURE 39. SWEDEN EUROPE DIALYSIS MARKET VALUE, BY DIALYSIS TYPE 2023-2030, (MILLION USD)

FIGURE 40. SWEDEN EUROPE DIALYSIS MARKET VALUE, BY PRODUCTS AND SERVICES 2023-2030, (MILLION USD)

FIGURE 41. SWEDEN EUROPE DIALYSIS MARKET VALUE, BY END USER 2023-2030, (MILLION USD)

FIGURE 42. NORWAY EUROPE DIALYSIS MARKET VALUE, BY DIALYSIS TYPE 2023-2030, (MILLION USD)

FIGURE 43. NORWAY EUROPE DIALYSIS MARKET VALUE, BY PRODUCTS AND SERVICES 2023-2030, (MILLION USD)

FIGURE 44. NORWAY EUROPE DIALYSIS MARKET VALUE, BY END USER 2023-2030, (MILLION USD)

FIGURE 45. DENMARK EUROPE DIALYSIS MARKET VALUE, BY DIALYSIS TYPE 2023-2030, (MILLION USD)

FIGURE 46. DENMARK EUROPE DIALYSIS MARKET VALUE, BY PRODUCTS AND SERVICES 2023-2030, (MILLION USD)

FIGURE 47. DENMARK EUROPE DIALYSIS MARKET VALUE, BY END USER 2023-2030, (MILLION USD)

FIGURE 48. NETHERLANDS EUROPE DIALYSIS MARKET VALUE, BY DIALYSIS TYPE 2023-2030, (MILLION USD)

FIGURE 49. NETHERLANDS EUROPE DIALYSIS MARKET VALUE, BY PRODUCTS AND SERVICES 2023-2030, (MILLION USD)

FIGURE 50. NETHERLANDS EUROPE DIALYSIS MARKET VALUE, BY END USER 2023-2030, (MILLION USD)

FIGURE 51. REST OF EUROPE EUROPE DIALYSIS MARKET VALUE, BY DIALYSIS TYPE 2023-2030, (MILLION USD)

FIGURE 52. REST OF EUROPE EUROPE DIALYSIS MARKET VALUE, BY PRODUCTS AND SERVICES 2023-2030, (MILLION USD)

FIGURE 53. REST OF EUROPE EUROPE DIALYSIS MARKET VALUE, BY END USER 2023-2030, (MILLION USD)

FIGURE 54. BAXTER INTERNATIONAL INC.: NET SALES, (2021-2023)

FIGURE 55. BAXTER INTERNATIONAL INC.: PRIMARY MARKET COMPETITORS

FIGURE 56. DAVITA INC.: NET SALES, (2021-2023)

FIGURE 57. DAVITA INC.: PRIMARY MARKET COMPETITORS

FIGURE 58. NIKKISO CO. LTD.: NET SALES, (2021-2023)

FIGURE 59. NIKKISO CO. LTD.: PRIMARY MARKET COMPETITORS

FIGURE 60. NXSTAGE MEDICAL, INC.: NET SALES, (2021-2023)

FIGURE 61. NXSTAGE MEDICAL, INC.: PRIMARY MARKET COMPETITORS

FIGURE 62. ASAHI KASEI CORPORATION: NET SALES, (2021-2023)

FIGURE 63. ASAHI KASEI CORPORATION: PRIMARY MARKET COMPETITORS

FIGURE 64. MEDICATORS, INC.: NET SALES, (2021-2023)

FIGURE 65. MEDICATORS, INC.: PRIMARY MARKET COMPETITORS

FIGURE 66. FRESENIUS MEDICAL CARE AG AND CO. KGAA: NET SALES, (2021-2023)

FIGURE 67. FRESENIUS MEDICAL CARE AG AND CO. KGAA: PRIMARY MARKET COMPETITORS

FIGURE 68. NIPRO CORPORATION: NET SALES, (2021-2023)

FIGURE 69. NIPRO CORPORATION: PRIMARY MARKET COMPETITORS

FIGURE 70. B. BRAUN AVITUM AG: NET SALES, (2021-2023)

FIGURE 71. B. BRAUN AVITUM AG: PRIMARY MARKET COMPETITORS

FIGURE 72. DIAVERUM DEUTSCHLAND GMBH: NET SALES, (2021-2023)

FIGURE 73. DIAVERUM DEUTSCHLAND GMBH: PRIMARY MARKET COMPETITORS

KEY PLAYERS

  • Baxter International, Inc.

  • DaVita Inc.

  • Nikkiso Co. Ltd.

  • NxStage Medical, Inc.

  • Asahi Kasei Corporation

  • Medicators, Inc.

  • Fresenius Medical Care AG & Co. KGaA

  • Nipro Corporation

  • B. Braun Avitum AG

  • Diaverum Deutschland GmbH


Frequently Asked Questions
Which are the top companies operating in the Europe dialysis market?

The leading companies in Europe dialysis market include Fresenius Medical Care AG & Co. KGaA, Baxter International Inc., DaVita Inc., Nipro Corporation, B. Braun Melsungen AG, and others.

What is the estimated revenue of the Europe dialysis market by the end of 2030?

According to projections from Next Move Strategy Consulting, the Europe dialysis market is anticipated to reach USD 46.61 billion by 2030.

What are the key challenges faced by the Europe dialysis market?

The significant challenges in the Europe dialysis market is the inherent risk of infections and complications associated with these procedures.

Which is the dominating region in the Europe dialysis market?

Germany is the dominant region in the Europe dialysis market.

What is the market size of the dialysis market in 2023?

The Europe dialysis market was valued at USD 35.93 billion in 2023, as per the findings of Next Move Strategy Consulting's report.